Language selection

Government of Canada / Gouvernement du Canada

Search

Respiratory Virus Report, Week 16 - ending April 20, 2024

Download in PDF format
(761 KB, 13 pages)

Organization: Public Health Agency of Canada

Please note that the Respiratory Virus Detection Surveillance System (RVDSS) is a sentinel laboratory surveillance system that does not capture all respiratory virus testing performed in Canada; differences may exist between the data presented in this report and provincial/territorial epidemiological reports. SARS-CoV-2 laboratory data is included in this report to facilitate the comparison of positivity with other respiratory viruses. Interpretation should be made with caution as testing practices differ among viruses.

For additional SARS-CoV-2 surveillance information, please refer to the COVID-19 epidemiology update.

Overall summary

In week 16 (week ending April 20, 2024) in Canada, percent positivity is currently highest for enterovirus/rhinovirus among respiratory viruses under surveillance. The following results were reported from RVDSS laboratories:

  • Following several months of decrease, national SARS-CoV-2 percent positivity is currently stable (1,280 detections; 4.8% positive) and below the most recent peak recorded in November 2023 (19.3% positive).
  • Influenza percent positivity is decreasing (1,647 detections; 6.4% positive) as percent positivity has decreased in recent weeks for both influenza A (348 detections; 1.3% positive) and influenza B (1,299 detections; 5.0% positive).
  • RSV percent positivity is stable (373 detections; 1.7% positive).
  • Percent positivity of all other non-SARS-CoV-2 respiratory viruses is near expected levels typical of this time of year.
  • 35/35 sentinel laboratories reported surveillance data

On this page

Abbreviations:
ADV
Adenovirus
Atl
Atlantic Canada
BC
British Columbia
Can
Canada
EORLA
Eastern Ontario Regional Laboratory Association
EV/RV
Enterovirus/Rhinovirus
Flu
Influenza
Flu A(H1)pdm09
Influenza A(H1N1)pdm09
Flu A(H3)
Influenza A(H3N2)
Flu A(UnS)
Influenza A(Unsubtyped)
HCoV
Human coronavirus 229E/OC43/NL63/HKU1
HMPV
Human metapneumovirus
HPIV
Human parainfluenza virus
HSC
Health Sciences Centre
N.C.
Data not collected
N.R.
Data not reported for current week
ON
Ontario
PR
Prairies
P.H.O.L.
Public Health Ontario Laboratory
QC
Quebec
RSV
Respiratory syncytial virus
RVDSS
Respiratory Virus Detection Surveillance System
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Terr
Territories of Canada
UHN
University Health Network

Respiratory virus detections

Table 1: Respiratory virus detections for the week ending April 20, 2024 (surveillance week 2024-16)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 582 70 437 0 0 7 7 7 437 16 437 1 1 30 0 0 437 9 437 31 437 36 437 29
Prince Edward Island 108 5 98 0 0 0 0 6 98 1 14 0 0 3 0 0 14 0 14 0 14 5 14 0
Nova Scotia 1325 80 1393 0 0 61 61 62 985 15 35 0 0 1 0 0 35 1 35 1 35 4 35 6
New Brunswick 955 38 950 3 1 0 4 59 950 11 82 0 0 8 0 0 82 4 82 3 82 21 82 1
Atlantic 2970 193 2878 3 1 68 72 134 2470 43 568 1 1 42 0 0 568 14 568 35 568 66 568 36
Région Nord-Est 1251 29 1294 0 0 0 0 136 645 21 99 0 0 5 0 0 99 4 95 10 N.C. N.C. 99 7
Québec-Chaudière-Appalaches 1283 44 1599 0 0 13 13 140 1508 33 651 0 0 5 0 0 668 11 651 43 N.C. N.C. 494 30
Centre-du-Québec 1580 30 1470 0 0 17 17 104 645 19 22 0 0 1 0 0 22 0 22 1 N.C. N.C. 22 0
Montréal-Laval 1734 44 2326 0 0 35 35 123 1401 42 797 0 0 38 1 0 797 18 801 60 N.C. N.C. 797 26
Ouest du Québec 1049 21 681 0 0 15 15 42 679 4 22 0 0 1 0 0 22 3 22 6 N.C. N.C. 22 0
Montérégie 1024 21 1237 0 0 11 11 52 1234 29 9 0 0 0 0 0 9 0 9 0 N.C. N.C. 9 0
Province of Québec 7921 189 8607 0 0 91 91 597 6112 148 1600 0 0 50 1 0 1617 36 1600 120 N.C. N.C. 1443 63
P.H.O.L. - Ottawa 253 42 172 1 0 2 3 3 172 9 108 0 0 0 0 9 108 0 108 12 108 4 108 10
EORLA 762 9 511 0 0 10 10 24 511 7 42 1 0 2 0 0 42 0 42 1 42 4 42 2
P.H.O.L. - Kingston 126 19 113 1 0 0 1 1 113 0 70 0 0 0 0 4 70 1 70 9 70 3 70 10
UHN / Mount Sinai Hospital 870 28 659 0 0 7 7 3 659 3 82 0 0 2 0 0 82 0 82 0 82 4 82 0
P.H.O.L. - Toronto 325 30 874 12 5 14 24 8 874 2 816 0 0 0 0 89 816 9 816 76 816 80 816 69
Sick Kids Hospital - Toronto 96 1 87 1 0 0 1 8 87 0 87 0 0 1 0 0 87 1 87 5 87 34 87 2
Shared Hospital Laboratory 1317 43 971 3 6 1 10 17 971 1 969 0 0 0 0 14 969 6 971 27 971 46 971 11
P.H.O.L. - Sault Ste. Marie 23 0 34 0 0 0 0 1 34 0 21 0 0 0 0 5 21 0 21 0 21 1 21 2
P.H.O.L. - Timmins 19 2 25 1 0 0 1 3 25 0 23 0 0 0 0 2 23 0 23 0 23 1 23 2
St. Joseph's - London 589 9 477 0 0 11 11 7 477 5 69 0 0 0 0 1 69 4 69 4 69 7 65 5
P.H.O.L. - London 241 25 218 5 3 0 4 6 218 2 202 0 0 0 0 18 202 2 202 17 202 11 202 22
P.H.O.L. - Orillia 14 2 10 1 0 0 1 0 10 0 9 0 0 0 0 0 9 0 9 1 9 0 9 1
P.H.O.L. - Thunder Bay 44 14 34 0 1 0 1 6 34 0 28 0 0 0 0 3 28 0 28 0 28 4 28 1
P.H.O.L. - Sudbury 29 4 39 0 0 0 0 0 39 0 35 0 0 0 0 1 35 0 35 3 35 8 35 2
P.H.O.L. - Hamilton 50 4 91 0 0 0 0 1 91 0 84 0 0 0 0 3 84 4 84 5 84 15 84 4
P.H.O.L. - Peterborough 67 19 80 0 0 0 0 1 80 0 58 0 0 0 0 11 58 1 58 4 58 3 58 1
St. Joseph's - Hamilton 1502 31 1460 0 0 16 16 50 1460 11 1460 0 0 68 0 0 1460 14 1460 75 1460 95 0 0
Sault Area Hospital 142 16 121 0 4 1 5 1 121 0 106 1 0 7 0 0 106 0 106 11 106 14 106 2
Province of Ontario 6469 298 5976 25 19 62 95 140 5976 40 4269 2 0 80 0 160 4269 42 4271 250 4271 334 2807 146
Manitoba 1260 94 869 0 1 11 12 51 869 10 108 1 0 4 0 0 108 3 109 6 108 14 109 6
Saskatchewan 1347 50 980 0 0 4 4 75 816 33 335 0 0 29 0 0 335 5 335 9 335 30 335 28
Alberta 3497 176 4055 4 11 0 21 235 3868 45 1041 3 0 47 0 0 1041 9 959 3 1022 94 1041 47
Prairies 6104 320 5904 4 12 15 37 361 5553 88 1484 4 0 80 0 0 1484 17 1403 18 1465 138 1485 81
British Columbia 3013 267 2320 28 10 3 53 53 2238 37 776 3 1 52 1 0 771 24 771 35 755 125 755 29
Yukon 41 0 27 0 0 0 0 3 27 0 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 29 0 28 0 0 0 0 4 28 0 N.C. N.C. N.C. N.C. N.C. N.C. 28 1 28 0 28 6 N.C. N.C.
Nunavut 164 13 136 0 0 0 0 7 136 17 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 234 13 191 0 0 0 0 14 191 17 N.C. N.C. N.C. N.C. N.C. N.C. 28 1 28 0 28 6 N.C. N.C.
CANADA 26711 1280 25876 60 42 239 348 1299 22540 373 8697 10 2 304 2 160 8737 134 8641 458 7087 669 7058 355

The data in the RVDSS report represent surveillance data available at the time of writing. Data missing from the current week are denoted by N.R. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively.

Table 2: Cumulative respiratory virus detections from August 27, 2023 to April 20, 2024 (surveillance weeks 2023-35 to 2024-16)
Reporting Laboratory SARS-CoV-2 Tested SARS-CoV-2 Positive Flu Tested A(H1)pdm09 Positive A(H3) Positive A(UnS) Positive Total Flu A Positive Total Flu B Positive RSV Tested RSV Positive HPIV Tested HPIV 1 Positive HPIV 2 Positive HPIV 3 Positive HPIV 4 Positive Other HPIV Positive ADV Tested ADV Positive HMPV Tested HMPV Positive EV/RV Tested EV/RV Positive HCoV Tested HCoV Positive
Newfoundland 20960 3011 15404 0 0 1335 1335 140 15404 965 15404 19 74 101 106 0 15404 255 15404 369 15404 1216 15404 444
Prince Edward Island 7645 789 5038 0 0 542 542 231 5038 373 563 3 0 19 8 0 562 35 552 22 563 145 547 28
Nova Scotia 48549 8588 35016 0 0 2795 2795 515 28603 1453 1176 16 3 6 10 0 1176 43 1169 13 1176 232 1175 26
New Brunswick 36894 3968 34862 899 26 1906 2831 911 34458 1906 3127 8 4 44 32 0 3127 115 3127 97 3127 616 3127 128
Atlantic 114048 16356 90320 899 26 6578 7503 1797 83503 4697 20270 46 81 170 156 0 20269 448 20252 501 20270 2209 20253 626
Région Nord-Est 56532 7157 51909 5 0 4729 4734 1094 20985 1474 2707 16 12 38 18 0 2707 114 2636 121 N.C. N.C. 2707 133
Québec-Chaudière-Appalaches 65341 9397 46493 0 0 5572 5572 1767 44566 2782 17857 22 9 47 14 0 18396 548 17857 614 N.C. N.C. 14613 550
Centre-du-Québec 81883 12508 43143 0 0 4595 4595 1138 24601 1668 1212 15 8 24 7 0 1212 60 1212 54 N.C. N.C. 1244 45
Montréal-Laval 97630 14008 83963 5 2 6734 6741 996 53540 2983 28483 95 43 362 25 0 28483 561 28560 755 N.C. N.C. 28483 1011
Ouest du Québec 53710 10086 23775 4 0 2120 2124 406 23544 1116 650 11 3 25 7 0 650 51 650 28 N.C. N.C. 650 29
Montérégie 52411 8076 44015 0 0 3261 3261 454 42931 1847 240 1 0 1 2 0 240 8 240 5 N.C. N.C. 240 3
Province of Québec 407507 61232 293298 14 2 27011 27027 5855 210167 11870 51149 160 75 497 73 0 51688 1342 51155 1577 N.C. N.C. 47937 1771
P.H.O.L. - Ottawa 11371 3861 8058 300 54 197 426 44 8052 147 4814 0 0 0 0 137 4814 13 4812 134 4814 436 4812 300
EORLA 41753 4578 20001 0 0 1628 1628 447 20001 1140 1340 3 5 37 4 0 1315 14 1340 37 1340 238 1340 44
P.H.O.L. - Kingston 7796 2151 4514 139 19 96 228 8 4514 168 3098 0 0 0 0 85 3098 12 3098 37 3098 335 3098 164
UHN / Mount Sinai Hospital 36288 3085 23099 41 10 568 619 88 23099 229 1599 0 0 25 2 0 1599 3 1599 17 1599 77 1599 47
P.H.O.L. - Toronto 19583 5536 36395 1203 917 359 1822 264 36386 1056 33439 0 0 0 0 1264 33447 397 33424 860 33439 3092 33424 1785
Sick Kids Hospital - Toronto 4293 319 3867 106 100 20 226 72 3867 313 3867 15 12 97 21 0 3867 103 3867 128 3867 739 3867 119
Shared Hospital Laboratory 58337 4625 48768 869 537 295 1701 445 48775 1345 48530 0 0 0 0 346 42876 352 48617 321 48635 1585 48639 552
P.H.O.L. - Sault Ste. Marie 515 207 645 55 3 17 69 3 645 46 442 0 0 0 0 10 442 1 442 0 442 27 442 46
P.H.O.L. - Timmins 1168 331 1212 67 10 30 96 11 1212 67 968 0 0 0 0 29 968 5 968 14 968 59 968 50
St. Joseph's - London 29323 3522 16468 0 0 1000 1000 257 16454 736 2274 0 0 0 0 40 2293 39 2293 47 2295 250 2293 73
P.H.O.L. - London 15081 4194 11365 492 146 169 618 112 11362 476 9191 0 0 0 0 304 9191 42 9189 162 9191 787 9189 394
P.H.O.L. - Orillia 594 152 1272 73 17 11 101 0 1269 74 1202 0 0 0 0 31 1202 16 1202 20 1202 145 1202 27
P.H.O.L. - Thunder Bay 1958 529 1255 64 1 8 45 11 1252 30 1047 0 0 0 0 33 1047 6 1047 32 1047 63 1047 29
P.H.O.L. - Sudbury 793 243 960 45 1 23 69 2 958 26 690 0 0 0 0 25 691 2 690 14 690 60 690 65
P.H.O.L. - Hamilton 7183 2116 6006 149 66 98 258 41 6005 172 4545 0 0 0 0 147 4545 89 4544 123 4545 580 4544 218
P.H.O.L. - Peterborough 2462 698 2547 207 205 73 155 32 2537 222 1982 0 0 0 0 86 1982 40 1982 62 1982 301 1982 60
St. Joseph's - Hamilton 63674 5904 57007 0 0 3246 3246 860 57007 1786 57007 0 0 663 0 0 57007 366 57007 856 57007 3283 0 0
Sault Area Hospital 6182 822 4244 182 24 56 262 21 4237 205 3354 28 0 35 17 0 3305 40 3305 60 3305 288 3315 74
Province of Ontario 308354 42873 247683 3992 2110 7894 12569 2718 247632 8238 179389 46 17 857 44 2537 173689 1540 179426 2924 179466 12345 122451 4047
Manitoba 54074 7518 40756 146 13 1891 2050 573 40756 1396 3192 4 11 34 42 0 3192 128 3967 161 3192 563 3967 149
Saskatchewan 69050 7506 47876 142 22 5427 5591 1983 42583 1688 15526 31 9 181 25 0 15526 287 15526 801 15526 1482 15526 456
Alberta 179951 20229 159958 11815 822 588 13299 4027 149654 6279 44123 145 93 740 3 0 44111 502 42542 35 43415 3984 44122 1200
Prairies 303075 35253 248590 12103 857 7906 20940 6583 232993 9363 62841 180 113 955 70 0 62829 917 62035 997 62133 6029 63615 1805
British Columbia 128041 16785 129208 4119 846 268 8809 1237 126067 5968 30651 122 186 452 188 0 30648 953 30533 1236 29458 4392 29435 953
Yukon 1795 180 1176 35 15 0 63 17 1167 46 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Northwest Territories 1265 77 1202 167 7 1 175 58 1202 173 N.C. N.C. N.C. N.C. N.C. N.C. 1003 46 1003 10 1202 148 N.C. N.C.
Nunavut 4770 397 3468 433 34 52 519 226 3468 504 N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C. N.C.
Territories 7830 654 5846 635 56 53 757 301 5837 723 N.C. N.C. N.C. N.C. N.C. N.C. 1003 46 1003 10 1202 148 N.C. N.C.
CANADA 1268855 173153 1014945 21762 3897 49710 77605 18491 906199 40859 344300 554 472 2931 531 2537 340126 5246 344404 7245 292529 25123 283691 9202

The data in the RVDSS report represent surveillance data available at the time of writing. Data not collected by reporting lab denoted by N.C.

Some specimens from Yukon (YT) are sent to reference laboratories in British Columbia and reported results reflect specimens identified as originating from YT.

Results from British Columbia comprise of specimens from the following sites: Children's and Women's Hospital Laboratory, Fraser Health Medical Microbiology Laboratory, Island Health, Providence Health Care, Vancouver Coastal Health sites, Victoria General Hospital, BCCDC Public Health Laboratory, Interior Health Authority sites and Northern Health Authority sites.

Due to different testing protocols of laboratories across Canada, influenza A subtype detection counts may not be included in total influenza A detection counts. Total influenza A and B positive counts are used to calculate percentage of tests positive.

Delays in the reporting of data may cause data to change retrospectively. Due to these delays, the sum of weekly report totals do not add up to cumulative totals.

Positive respiratory virus tests historical comparison

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 1

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: SARS-CoV-2 surveillance was integrated into RVDSS at the beginning of the 2022-2023 season; no prior data is available for historical comparison.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Figure 1: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus tests (%) reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 SARS-CoV-2% 2022-2023 SARS-CoV-2% 2023-2024 A% 2022-2023 A% 2021-2022 A% Max A% Base Min A% Base Av A% Base 2023-2024 B% 2022-2023 B% 2021-2022 B% Max B% Base Min B% Base Av B% Base 2023-2024 RSV% 2022-2023 RSV% 2021-2022 RSV% Max RSV% Base Min RSV% Base Av RSV% Base
35 2023-09-02 14.40 13.40 0.69 0.18 0.04 1.60 0.11 0.67 0.06 0.02 0.00 0.28 0.00 0.14 0.58 1.12 4.43 1.34 0.38 0.61
36 2023-09-09 15.92 13.07 0.43 0.14 0.01 2.11 0.23 0.99 0.06 0.04 0.00 0.55 0.00 0.15 0.71 1.12 6.61 1.09 0.22 0.62
37 2023-09-16 16.49 12.74 0.48 0.23 0.03 1.59 0.35 0.87 0.03 0.01 0.00 0.19 0.04 0.12 0.82 1.06 7.59 1.37 0.38 0.65
38 2023-09-23 18.60 13.62 0.51 0.48 0.00 2.15 0.43 1.17 0.02 0.02 0.00 0.21 0.00 0.14 1.15 1.47 7.16 1.24 0.37 0.67
39 2023-09-30 19.59 14.44 0.51 0.67 0.01 2.65 0.50 1.52 0.09 0.03 0.00 0.29 0.09 0.18 1.14 2.14 8.48 1.29 0.51 0.72
40 2023-10-07 19.81 15.06 0.64 0.96 0.00 2.17 1.01 1.58 0.05 0.03 0.02 0.20 0.05 0.11 1.35 2.54 8.53 1.39 0.34 0.71
41 2023-10-14 17.55 16.59 0.49 1.42 0.03 2.66 1.05 1.56 0.03 0.01 0.03 0.36 0.03 0.16 1.80 3.65 9.54 1.74 0.58 1.03
42 2023-10-21 17.78 15.39 0.73 2.36 0.03 2.96 0.77 1.92 0.08 0.05 0.02 0.45 0.05 0.25 2.38 4.63 8.18 2.11 0.63 1.25
43 2023-10-28 17.89 15.78 1.16 5.47 0.03 5.19 0.68 2.59 0.10 0.03 0.02 0.55 0.06 0.23 3.25 6.76 8.11 2.16 0.55 1.41
44 2023-11-04 17.74 13.91 2.63 10.75 0.10 8.32 1.08 3.35 0.10 0.03 0.10 0.71 0.12 0.31 4.07 7.77 7.82 3.35 0.83 2.07
45 2023-11-11 18.17 12.43 4.93 16.19 0.07 9.83 1.18 4.19 0.14 0.04 0.06 0.97 0.22 0.44 5.12 7.68 7.03 4.43 1.29 2.71
46 2023-11-18 18.80 11.96 7.24 20.23 0.10 13.89 1.42 5.43 0.16 0.05 0.06 1.49 0.09 0.57 5.85 7.54 7.18 6.33 1.38 3.60
47 2023-11-25 19.31 11.76 8.81 24.27 0.13 15.25 1.25 6.91 0.12 0.04 0.07 2.13 0.13 0.80 6.81 6.66 8.10 8.69 1.79 4.79
48 2023-12-02 18.03 12.12 11.62 24.04 0.19 18.07 0.76 9.40 0.26 0.03 0.15 3.18 0.08 1.20 6.99 6.87 8.92 9.47 3.11 6.08
49 2023-12-09 17.53 12.61 14.74 21.12 0.23 19.13 1.43 11.34 0.29 0.06 0.05 4.21 0.19 1.60 7.38 7.29 10.09 12.26 5.40 7.54
50 2023-12-16 17.78 13.10 15.32 17.31 0.23 26.42 1.97 13.93 0.36 0.06 0.02 7.50 0.15 2.48 7.26 8.61 10.78 13.19 6.42 8.55
51 2023-12-23 16.81 14.09 16.78 12.50 0.18 28.53 2.27 16.69 0.45 0.05 0.02 10.44 0.19 3.30 7.29 9.16 8.97 15.23 7.40 9.92
52 2023-12-30 15.35 15.53 18.18 7.93 0.09 33.97 3.30 20.32 0.52 0.07 0.01 12.58 0.23 4.04 7.41 10.59 6.72 17.80 7.89 10.97
1 2024-01-06 14.51 15.03 14.49 4.54 0.08 30.93 4.58 19.59 0.60 0.07 0.00 10.34 0.22 3.87 7.10 10.34 5.26 15.62 8.37 10.84
2 2024-01-13 13.03 13.38 11.16 2.21 0.11 26.80 5.46 19.11 0.56 0.05 0.01 11.01 0.29 3.91 6.26 9.07 4.32 14.05 7.45 10.24
3 2024-01-20 11.35 12.21 10.27 1.40 0.04 28.20 9.13 18.95 0.79 0.14 0.01 12.75 0.35 4.70 6.13 8.43 3.42 15.56 7.90 10.95
4 2024-01-27 10.19 11.30 11.10 0.91 0.05 27.01 12.34 18.82 1.08 0.14 0.00 12.74 0.41 5.17 5.85 7.96 2.33 15.88 8.38 11.89
5 2024-02-03 9.34 11.51 11.28 0.76 0.03 23.66 15.78 19.15 1.48 0.28 0.01 14.84 0.41 5.77 5.91 7.15 2.19 16.33 8.77 12.14
6 2024-02-10 8.79 11.88 10.37 0.67 0.04 23.36 15.68 18.80 1.74 0.34 0.01 16.23 0.44 6.22 5.21 5.78 2.10 15.79 7.98 12.32
7 2024-02-17 8.12 11.79 9.43 0.57 0.02 24.22 15.48 18.53 2.18 0.29 0.00 17.02 0.35 6.56 4.49 5.13 2.16 15.53 8.42 11.89
8 2024-02-24 7.49 11.73 8.01 0.57 0.06 28.62 12.42 18.57 3.17 0.49 0.02 16.79 0.45 6.61 4.78 4.53 2.12 15.47 8.04 11.28
9 2024-03-02 7.03 11.18 6.72 0.63 0.12 29.30 11.04 18.13 4.03 0.70 0.00 15.45 0.74 6.25 3.79 3.70 2.50 15.62 7.59 10.52
10 2024-03-09 6.24 11.41 5.55 0.63 0.16 29.65 8.51 16.84 5.12 0.77 0.00 14.86 0.81 6.42 3.64 2.80 3.10 14.97 6.92 9.92
11 2024-03-16 6.13 11.58 4.36 0.52 0.26 24.27 6.74 14.55 5.42 1.15 0.01 13.11 1.05 6.86 3.18 2.18 3.71 12.11 6.29 9.33
12 2024-03-23 5.17 11.28 3.30 0.59 0.86 20.91 5.51 12.68 5.82 1.29 0.00 11.53 1.51 7.43 2.49 1.98 3.79 10.70 6.46 8.59
13 2024-03-30 4.85 10.85 2.71 0.64 1.52 18.09 4.67 11.66 6.60 1.72 0.00 12.55 1.98 7.90 2.32 1.63 4.00 9.32 6.45 8.11
14 2024-04-06 4.72 10.91 2.28 0.38 2.48 24.10 3.21 11.23 6.76 1.84 0.01 13.12 2.14 7.89 2.08 1.33 4.05 8.09 6.06 6.91
15 2024-04-13 4.91 11.37 1.80 0.59 3.84 17.75 2.18 8.72 6.02 1.92 0.02 12.22 2.00 7.55 1.79 1.40 3.46 7.73 5.34 6.34
16 2024-04-20 4.79 10.93 1.34 0.52 6.98 13.67 2.13 6.80 5.02 1.86 0.01 11.94 2.56 7.68 1.65 1.31 2.97 6.64 4.40 5.65
Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Figure 2

Shaded area represents the maximum and minimum % of respiratory virus tests positive reported by week from seasons 2014-2015 to 2019-2020

Note: Changes to testing practices during the COVID-19 pandemic may cause substantial changes to indicator estimates from previous years. Collection of laboratory testing practice meta-data to understand these changes is ongoing. Interpret trends with caution.

Note: Data from week 11 of the 2019-2020 season onwards are excluded from the historical comparison due to the COVID-19 pandemic.

Note: % Tests Positive scale changes across the dashed line

Figure 2: Positive tests (%) of other respiratory viruses reported by participating laboratories in Canada by surveillance week compared to average and range from 2014-2015 to 2019-2020 season
Week Week end 2023-2024 EV/RV% 2022-2023 EV/RV% 2021-2022 EV/RV% Max EV/RV% Base Min EV/RV% Base Av EV/RV% Base 2023-2024 HPIV% 2022-2023 HPIV% 2021-2022 HPIV% Max HPIV% Base Min HPIV% Base Av HPIV% Base 2023-2024 ADV% 2022-2023 ADV% 2021-2022 ADV% Max ADV% Base Min ADV% Base Av ADV% Base 2023-2024 HMPV% 2022-2023 HMPV% 2021-2022 HMPV% Max HMPV% Base Min HMPV% Base Av HMPV% Base 2023-2024 HCoV% 2022-2023 HCoV% 2021-2022 HCoV% Max HCoV% Base Min HCoV% Base Av HCoV% Base
35 2023-09-02 12.50 15.47 21.96 27.19 22.44 24.71 1.99 2.80 5.99 3.16 1.15 2.44 1.62 2.28 1.18 1.74 0.99 1.43 0.34 1.80 0.23 2.04 0.10 0.78 0.28 0.53 1.05 0.76 0.18 0.45
36 2023-09-09 14.85 16.22 18.59 30.69 23.30 26.31 1.49 3.21 4.93 3.31 1.35 2.32 1.52 2.18 1.15 2.85 1.42 1.87 0.39 1.81 0.24 0.84 0.10 0.48 0.42 0.38 0.62 0.38 0.12 0.22
37 2023-09-16 18.29 21.73 27.46 33.58 27.74 31.69 1.60 3.02 5.97 3.26 1.65 2.40 1.47 2.10 0.81 2.44 1.38 1.86 0.39 1.38 0.17 1.61 0.00 0.51 0.23 0.28 0.44 0.56 0.00 0.26
38 2023-09-23 20.25 23.50 33.19 39.57 32.80 35.83 1.77 2.42 4.73 2.87 1.92 2.33 0.93 1.58 0.82 2.04 1.11 1.63 0.38 1.61 0.37 1.43 0.06 0.48 0.46 0.32 0.67 1.36 0.06 0.43
39 2023-09-30 18.52 22.89 30.01 40.59 34.87 37.68 1.32 3.09 8.12 3.01 1.70 2.24 1.15 2.21 1.14 2.27 1.04 1.66 0.51 1.43 0.17 0.72 0.05 0.29 0.28 0.59 0.62 0.66 0.07 0.45
40 2023-10-07 17.45 19.32 26.26 41.29 33.00 35.43 1.34 3.69 8.19 3.28 1.90 2.43 1.41 1.79 1.31 2.25 1.39 1.82 0.32 1.49 0.16 0.92 0.05 0.34 0.26 0.93 0.57 1.08 0.22 0.59
41 2023-10-14 15.74 16.70 22.91 33.62 26.94 29.93 1.28 3.52 10.46 3.70 1.96 2.75 1.38 2.03 1.37 1.91 1.28 1.70 0.37 1.66 0.20 0.95 0.04 0.46 0.32 0.99 1.69 0.70 0.00 0.34
42 2023-10-21 13.12 12.95 22.16 32.62 24.54 27.86 1.59 4.22 10.01 3.89 2.64 3.21 1.43 1.65 2.54 2.39 1.47 1.86 0.46 1.58 0.15 0.89 0.15 0.40 0.17 1.16 1.07 1.18 0.20 0.49
43 2023-10-28 12.52 11.05 19.64 28.73 21.67 24.95 1.21 4.41 9.38 3.98 3.18 3.54 1.48 1.79 1.15 2.42 1.63 1.96 0.46 1.79 0.36 1.64 0.12 0.58 0.38 1.86 1.05 2.35 0.27 0.75
44 2023-11-04 10.83 10.23 21.45 23.82 16.75 21.38 1.44 4.14 10.28 4.81 2.94 3.72 1.76 2.02 1.42 2.88 1.18 2.21 0.55 1.79 0.77 1.08 0.23 0.48 0.37 2.54 2.21 2.59 0.21 0.88
45 2023-11-11 10.70 7.77 22.39 23.08 15.17 20.56 1.65 3.90 9.97 5.42 2.53 4.01 1.45 1.99 1.63 2.68 2.02 2.42 0.60 2.06 0.64 1.30 0.04 0.77 0.42 3.00 2.57 2.74 0.52 0.96
46 2023-11-18 8.64 6.93 21.37 22.77 15.28 19.24 1.39 3.97 8.29 5.72 1.62 4.14 2.03 1.87 2.51 2.90 1.99 2.52 0.79 1.89 0.99 1.43 0.18 0.81 0.65 3.54 2.99 3.32 0.46 1.25
47 2023-11-25 7.62 4.88 18.54 20.84 12.15 16.09 1.55 3.63 7.04 7.00 2.36 4.72 1.90 1.89 1.94 2.95 1.83 2.35 1.00 1.78 1.01 2.02 0.09 0.90 0.65 3.24 3.90 3.26 0.37 1.25
48 2023-12-02 6.79 4.74 16.64 16.72 12.69 13.84 1.51 3.04 5.78 6.14 3.03 4.18 2.15 1.87 1.89 3.34 1.66 2.49 0.91 1.86 1.48 1.94 0.31 1.09 0.76 3.94 4.94 4.30 1.00 2.04
49 2023-12-09 6.00 4.09 14.57 16.32 10.72 13.07 1.39 3.03 3.97 5.65 2.94 4.19 1.83 1.68 2.48 3.03 1.84 2.50 1.20 1.93 1.22 2.80 0.49 1.48 1.12 4.48 6.58 5.19 0.84 2.53
50 2023-12-16 5.90 4.58 12.40 13.85 8.43 10.91 1.46 2.98 3.23 5.95 2.54 4.22 2.00 2.29 2.72 3.13 1.49 2.42 1.31 1.92 1.08 3.32 0.46 1.68 1.47 5.13 7.26 6.04 1.54 3.16
51 2023-12-23 5.56 4.49 9.95 14.18 8.81 10.48 1.35 3.09 3.01 6.71 2.94 3.95 1.55 1.76 2.54 3.20 1.36 2.04 1.59 2.23 1.20 4.39 0.37 2.47 1.77 5.28 8.11 6.68 1.87 3.72
52 2023-12-30 4.71 4.50 7.71 14.41 6.24 9.26 1.35 3.32 2.13 5.08 2.87 3.75 1.76 1.80 1.92 2.59 1.20 1.76 1.76 2.75 1.00 3.81 0.41 2.49 2.48 4.73 10.33 6.73 2.78 4.73
1 2024-01-06 4.80 4.19 5.71 11.09 4.36 7.42 1.48 3.63 1.84 5.08 2.68 3.34 1.48 1.88 1.84 2.67 0.85 1.54 2.20 2.94 0.72 4.45 0.28 2.74 3.06 4.40 9.27 7.77 3.07 5.16
2 2024-01-13 4.43 4.71 3.98 9.55 4.31 6.79 1.17 3.24 1.19 4.12 2.46 3.05 1.25 1.87 1.13 2.15 0.87 1.37 1.64 2.61 0.38 4.76 0.42 2.69 3.19 4.01 7.46 7.89 2.84 5.45
3 2024-01-20 4.59 6.68 3.12 8.42 4.44 6.01 1.08 2.92 0.76 3.25 2.59 2.82 1.11 1.97 1.34 2.10 1.15 1.45 2.20 2.56 0.24 5.56 0.47 3.18 3.89 3.46 4.97 7.90 4.17 6.11
4 2024-01-27 4.37 8.22 2.60 9.04 4.89 6.41 1.16 2.78 0.64 3.12 1.77 2.55 1.56 2.35 1.18 1.83 1.11 1.49 2.11 2.71 0.23 5.19 0.55 3.05 5.19 2.63 3.92 7.86 3.79 6.09
5 2024-02-03 5.02 8.94 3.02 9.79 6.06 6.94 1.45 2.70 0.48 3.48 1.70 2.39 1.62 2.44 1.57 1.93 1.36 1.62 2.27 2.96 0.25 5.70 0.58 3.34 5.10 3.20 2.83 8.49 4.55 6.84
6 2024-02-10 6.26 9.97 3.86 9.89 6.16 6.98 1.56 2.68 0.51 2.89 1.57 2.19 1.84 2.14 1.44 1.74 1.25 1.51 2.54 3.73 0.42 5.57 0.65 3.48 6.80 2.64 3.01 8.57 3.48 6.75
7 2024-02-17 6.18 9.87 4.46 8.95 6.00 7.04 1.54 2.63 0.44 3.20 1.42 2.11 1.22 2.31 1.52 1.61 1.30 1.51 2.82 4.41 0.44 6.05 1.45 3.96 7.73 3.14 3.24 8.02 4.35 6.52
8 2024-02-24 6.21 9.55 6.31 8.35 5.20 6.94 1.84 2.55 0.73 3.21 1.31 2.25 1.30 2.86 1.85 2.00 1.38 1.66 3.15 4.29 0.53 5.74 1.19 4.19 8.28 3.07 3.67 8.29 4.21 6.61
9 2024-03-02 6.48 9.77 7.80 9.03 5.73 7.75 2.40 3.07 0.60 3.35 1.41 2.44 1.65 2.75 1.90 1.92 1.09 1.40 3.92 4.72 0.40 6.42 1.87 4.46 7.09 3.41 3.32 8.01 5.09 6.87
10 2024-03-09 6.52 9.42 8.24 10.16 5.53 8.08 2.74 2.77 0.68 4.18 1.19 2.69 1.31 2.79 1.98 2.23 1.50 1.78 4.57 5.05 0.51 6.74 2.26 4.94 6.84 3.71 3.86 8.34 4.28 6.99
11 2024-03-16 6.67 8.77 8.97 9.45 7.15 8.22 3.43 3.48 0.66 4.58 1.35 3.00 1.29 2.39 1.88 2.32 1.23 1.69 4.88 5.07 0.59 7.94 2.52 4.87 7.18 3.70 3.25 8.02 4.35 6.23
12 2024-03-23 6.63 9.31 9.52 10.26 8.58 9.63 4.10 2.98 1.05 4.95 1.26 3.33 1.42 2.60 1.71 2.13 1.82 1.96 4.63 5.40 0.77 6.69 3.65 5.35 6.79 4.50 4.38 6.99 3.95 5.67
13 2024-03-30 7.36 8.35 8.49 12.58 7.69 10.26 4.52 3.17 1.39 5.21 1.48 3.68 1.63 2.51 2.30 2.12 1.37 1.70 5.02 4.79 1.28 6.90 3.95 5.27 6.02 4.04 4.45 8.16 3.65 5.46
14 2024-04-06 7.54 8.95 9.25 13.59 8.46 12.00 4.52 3.45 1.18 6.26 1.67 4.30 1.58 2.56 1.74 2.31 1.50 1.86 5.14 4.61 1.45 7.70 4.14 5.99 6.77 4.51 4.24 7.79 3.84 4.86
15 2024-04-13 8.51 9.16 9.14 14.59 9.49 13.17 5.96 3.83 1.35 6.94 1.97 4.61 1.39 3.04 1.71 2.62 1.64 2.12 4.63 4.09 1.52 7.47 3.81 6.11 5.46 3.56 4.97 5.52 3.23 4.24
16 2024-04-20 9.44 8.67 8.20 16.10 10.84 13.77 5.50 3.89 2.19 7.88 1.97 5.20 1.53 2.79 1.84 3.21 1.85 2.32 5.30 3.93 2.18 7.16 3.71 6.04 5.03 3.64 4.91 4.99 3.51 4.32

Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Figure 3

Note: Differences in positivity between jurisdictions can reflect differences in testing practices. Please interpret with caution.

Figure 3: Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (%) in Canada by region by surveillance week
Week Week end Can Tests SARS-CoV-2% Atl Tests SARS-CoV-2% QC Tests SARS-CoV-2% ON Tests SARS-CoV-2% Pr Tests SARS-CoV-2% BC Tests SARS-CoV-2% Terr Tests SARS-CoV-2%
35 2023-09-02 25656 14.40 2110 16.92 9351 16.30 6230 12.39 5192 10.59 2651 18.03 122 11.48
36 2023-09-09 28237 15.92 2346 20.20 10215 17.37 6939 15.46 5968 11.90 2640 16.70 129 17.05
37 2023-09-16 31790 16.49 2567 18.62 11678 18.11 7337 15.66 6948 12.12 3111 20.64 149 10.07
38 2023-09-23 36264 18.60 2775 18.38 13455 20.48 8514 18.38 7969 14.23 3377 22.59 174 10.34
39 2023-09-30 40587 19.59 3126 22.65 15431 21.30 9291 17.86 8658 15.65 3895 23.59 186 12.90
40 2023-10-07 42173 19.81 3544 24.41 15684 22.19 9349 17.61 9198 15.96 4202 20.75 196 12.24
41 2023-10-14 38462 17.55 3583 20.74 12605 18.30 8426 15.27 9624 16.76 4047 19.13 177 14.69
42 2023-10-21 39350 17.78 3493 19.70 12590 18.63 9300 16.86 10040 17.16 3737 17.13 190 17.37
43 2023-10-28 37286 17.89 3095 17.74 12003 18.29 9276 19.35 9450 17.05 3262 14.87 200 17.50
44 2023-11-04 38183 17.74 2965 17.91 11975 18.42 9060 17.09 10341 18.12 3648 15.98 194 15.98
45 2023-11-11 38722 18.17 3122 20.12 11815 19.90 9607 18.24 10448 16.98 3545 14.41 185 10.81
46 2023-11-18 41432 18.80 3186 22.47 13182 20.21 10470 20.36 11134 16.80 3245 12.14 215 5.12
47 2023-11-25 42304 19.31 3490 22.35 12938 21.52 10880 22.17 11422 15.57 3385 11.96 189 6.35
48 2023-12-02 44713 18.03 3648 21.98 14100 22.18 11174 20.06 11903 12.58 3639 10.31 249 7.63
49 2023-12-09 46876 17.53 3654 20.17 14467 22.78 11644 18.67 12452 12.41 4272 10.30 387 6.98
50 2023-12-16 48215 17.78 4065 18.60 15835 23.97 12142 18.69 12089 11.16 3746 10.25 338 6.21
51 2023-12-23 48372 16.81 4353 15.81 16682 22.12 11548 18.73 11472 9.91 3952 10.55 365 9.86
52 2023-12-30 46997 15.35 4234 14.67 15739 19.65 11522 17.68 10314 9.95 4930 8.64 258 5.04
1 2024-01-06 48060 14.51 4471 12.68 15874 17.71 11545 16.83 10577 10.62 5300 9.57 293 7.17
2 2024-01-13 44189 13.03 4333 11.98 13921 14.75 11346 14.29 9475 9.91 4862 12.48 252 6.35
3 2024-01-20 38190 11.35 3750 10.64 11599 11.60 9942 12.87 8591 9.92 4141 10.92 167 4.19
4 2024-01-27 37089 10.19 3784 9.49 11052 9.79 9238 11.40 8358 8.95 4459 11.89 198 4.04
5 2024-02-03 36771 9.34 3908 8.75 10995 8.58 9011 9.75 8265 9.56 4420 10.63 172 5.81
6 2024-02-10 34740 8.79 3499 8.80 10544 7.33 8519 8.48 8042 10.12 3940 10.74 196 7.14
7 2024-02-17 35098 8.12 3185 8.92 11071 6.64 8901 7.48 8021 9.21 3722 11.04 198 7.07
8 2024-02-24 34145 7.49 3098 8.23 10925 5.10 8077 6.82 7890 8.66 3872 12.45 283 10.25
9 2024-03-02 33779 7.03 2992 7.02 10468 4.88 8299 6.21 7831 8.42 3972 11.76 217 6.45
10 2024-03-09 32484 6.24 3112 7.42 9479 3.46 7884 4.67 7845 7.71 3860 12.31 304 6.25
11 2024-03-16 32416 6.13 3346 6.90 9376 3.03 7702 5.47 7795 7.36 3904 11.63 293 7.51
12 2024-03-23 30991 5.17 3206 7.74 8609 2.25 7772 4.26 7547 6.15 3552 9.80 305 5.25
13 2024-03-30 29569 4.85 2831 6.85 8537 2.69 6962 4.28 7517 4.98 3450 9.25 272 7.35
14 2024-04-06 29672 4.72 2964 6.01 8696 2.38 7100 4.63 7336 4.43 3303 10.54 273 5.13
15 2024-04-13 29332 4.91 3243 6.38 8695 2.29 6878 5.18 7259 5.33 2987 9.24 270 5.93
16 2024-04-20 26711 4.79 2970 6.50 7921 2.39 6469 4.61 6104 5.24 3013 8.86 234 5.56

Positive influenza (Flu) tests

Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Figure 4
Figure 4: Positive influenza (Flu) tests (%) in Canada by region by surveillance week
Week Week end Can Tests Can A% Can B% Atl Tests Atl A% Atl B% QC Tests QC A% QC B% ON Tests ON A% ON B% Pr Tests Pr A% Pr B% BC Tests BC A% BC B% Terr Tests Terr A% Terr B%
35 2023-09-02 14543 0.69 0.06 984 0.00 0.00 3339 0.24 0.15 4324 0.39 0.09 3654 0.57 0.00 2158 2.46 0.00 84 2.38 0.00
36 2023-09-09 15430 0.43 0.06 1047 0.00 0.00 3649 0.19 0.03 4455 0.31 0.09 4069 0.37 0.05 2117 1.46 0.09 93 0.00 0.00
37 2023-09-16 18035 0.48 0.03 1216 0.08 0.00 4174 0.41 0.07 5145 0.29 0.00 4705 0.40 0.04 2703 1.29 0.04 92 0.00 0.00
38 2023-09-23 20121 0.51 0.02 1388 0.07 0.00 4734 0.30 0.00 5652 0.21 0.05 5325 0.62 0.02 2928 1.47 0.00 94 0.00 0.00
39 2023-09-30 21530 0.51 0.09 1403 0.14 0.07 4847 0.21 0.08 6186 0.37 0.11 5371 0.48 0.11 3598 1.36 0.06 125 0.00 0.00
40 2023-10-07 23658 0.64 0.05 1775 0.34 0.00 5628 0.37 0.04 6456 0.31 0.00 5803 0.74 0.16 3878 1.60 0.05 118 0.00 0.00
41 2023-10-14 23208 0.49 0.03 1938 0.57 0.00 4978 0.22 0.06 6283 0.30 0.00 6067 0.73 0.05 3828 0.73 0.03 114 0.00 0.00
42 2023-10-21 24067 0.73 0.08 2029 0.69 0.05 5110 0.37 0.02 6834 0.47 0.07 6370 1.13 0.13 3599 1.06 0.11 125 0.00 0.00
43 2023-10-28 23268 1.16 0.10 1979 0.96 0.00 5450 0.64 0.11 6814 0.50 0.06 5872 2.33 0.17 3039 1.45 0.10 114 0.88 0.00
44 2023-11-04 25317 2.63 0.10 1914 1.25 0.05 5705 0.63 0.07 6996 0.51 0.06 6996 6.80 0.17 3562 2.58 0.11 144 2.08 0.00
45 2023-11-11 26520 4.93 0.14 2069 2.03 0.14 5970 0.84 0.07 7240 1.22 0.07 7656 12.87 0.26 3460 3.96 0.14 125 4.00 0.00
46 2023-11-18 28583 7.24 0.16 2219 3.11 0.09 6454 1.36 0.09 7797 2.68 0.15 8734 18.14 0.26 3258 3.59 0.12 121 2.48 0.00
47 2023-11-25 29879 8.81 0.12 2521 4.60 0.04 6561 2.04 0.06 8070 2.69 0.02 9078 21.15 0.28 3517 6.43 0.09 132 15.15 0.00
48 2023-12-02 32859 11.62 0.26 2743 4.89 0.11 7199 3.78 0.15 8447 4.45 0.17 10485 24.44 0.47 3836 10.79 0.21 149 38.93 0.00
49 2023-12-09 34573 14.74 0.29 2817 9.66 0.11 8141 7.14 0.12 8466 7.08 0.21 11298 26.93 0.57 3590 13.12 0.11 261 49.81 0.00
50 2023-12-16 38612 15.32 0.36 3363 12.73 0.09 10087 11.63 0.12 9265 8.47 0.41 11116 24.56 0.71 4496 14.23 0.16 285 56.49 0.00
51 2023-12-23 40839 16.78 0.45 3820 19.08 0.31 12090 15.38 0.12 9246 11.39 0.51 10656 21.67 0.91 4747 16.64 0.29 280 40.36 0.00
52 2023-12-30 42482 18.18 0.52 3874 20.99 0.36 13501 19.37 0.07 9830 15.02 0.63 9720 17.61 1.26 5352 18.89 0.24 205 46.34 0.00
1 2024-01-06 43260 14.49 0.60 4132 17.91 0.36 13858 17.30 0.22 9869 11.67 0.54 9519 11.29 1.45 5634 14.55 0.39 248 33.47 0.00
2 2024-01-13 40233 11.16 0.56 3864 15.79 0.31 12702 15.32 0.19 9980 9.08 0.59 8491 5.94 1.33 4963 9.83 0.32 233 15.88 0.43
3 2024-01-20 35213 10.27 0.79 3422 14.23 0.94 11099 14.72 0.36 8812 8.65 0.45 7343 4.09 2.07 4397 9.71 0.34 140 5.71 0.00
4 2024-01-27 35174 11.10 1.08 3461 14.59 1.36 11277 17.65 0.28 8274 8.87 0.59 7261 2.31 2.91 4722 10.67 0.87 179 2.79 0.00
5 2024-02-03 35522 11.28 1.48 3608 14.61 2.02 12036 19.09 0.61 7738 8.30 1.02 7380 1.91 3.20 4626 8.58 1.25 134 2.24 2.99
6 2024-02-10 33997 10.37 1.74 3230 12.38 1.98 11857 18.01 1.05 7402 7.23 1.50 7230 1.77 3.28 4119 7.99 1.24 159 0.00 3.14
7 2024-02-17 33917 9.43 2.18 2882 8.78 2.74 11966 16.61 1.53 7689 7.40 1.87 7229 1.58 3.62 4006 6.81 1.40 145 1.38 11.03
8 2024-02-24 33294 8.01 3.17 2914 7.41 2.88 11748 14.22 2.63 7189 6.37 2.35 7030 1.07 5.65 4225 5.80 1.82 188 0.53 9.57
9 2024-03-02 32543 6.72 4.03 2834 7.13 4.13 11373 10.92 4.28 7133 5.72 2.90 6806 1.59 5.80 4231 5.25 1.96 166 2.41 13.25
10 2024-03-09 31700 5.55 5.12 2826 7.01 6.37 10775 8.84 5.27 6873 4.89 4.09 6835 1.29 6.63 4160 4.33 2.81 231 2.16 9.96
11 2024-03-16 30555 4.36 5.42 3170 6.03 4.95 9835 6.05 5.63 6948 3.94 3.80 6297 1.46 8.15 4077 4.42 3.63 228 0.44 8.77
12 2024-03-23 30633 3.30 5.82 3097 4.91 5.97 9578 3.82 5.54 6960 3.30 3.39 6918 1.45 9.35 3820 4.08 3.46 260 3.08 19.62
13 2024-03-30 29850 2.71 6.60 2909 3.82 7.25 9561 3.50 6.66 6384 2.44 3.29 7087 1.30 10.50 3681 3.07 3.15 228 0.88 23.25
14 2024-04-06 30169 2.28 6.76 2945 2.51 7.13 9682 2.55 8.14 6699 2.70 3.43 7167 1.48 9.24 3455 2.26 3.01 221 0.45 20.81
15 2024-04-13 29481 1.80 6.02 3049 2.76 5.02 9727 1.96 7.98 6251 1.70 3.47 7114 1.14 7.45 3106 2.03 2.29 234 2.56 11.97
16 2024-04-20 25876 1.34 5.02 2878 2.50 4.66 8607 1.06 6.94 5976 1.59 2.34 5904 0.63 6.11 2320 2.28 2.28 191 0.00 7.33

Positive respiratory syncytial virus (RSV) tests

Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Figure 5
Figure 5: Positive respiratory syncytial virus (RSV) tests (%) in Canada by region by surveillance week
Week Week end Can Tests RSV% Atl Tests RSV% QC Tests RSV% ON Tests RSV% Pr Tests RSV% BC Tests RSV% Terr Tests RSV%
35 2023-09-02 13610 0.58 969 0.00 2540 1.14 4324 0.81 3535 0.20 2158 0.32 84 1.19
36 2023-09-09 14361 0.71 1047 0.57 2750 1.64 4455 0.88 3915 0.18 2101 0.24 93 0.00
37 2023-09-16 16808 0.82 1201 0.25 3181 1.67 5138 1.01 4494 0.38 2702 0.41 92 1.09
38 2023-09-23 18782 1.15 1381 1.30 3652 2.27 5652 1.43 5075 0.37 2928 0.51 94 0.00
39 2023-09-30 20217 1.14 1392 0.79 3788 2.38 6186 1.42 5128 0.43 3598 0.56 125 0.00
40 2023-10-07 22042 1.35 1761 0.28 4333 2.75 6456 1.95 5496 0.36 3878 0.72 118 0.00
41 2023-10-14 21748 1.80 1927 0.83 3897 3.70 6281 2.48 5701 0.63 3828 1.04 114 0.00
42 2023-10-21 22479 2.38 2015 0.69 3889 4.78 6834 3.72 6017 0.58 3599 1.25 125 0.00
43 2023-10-28 21745 3.25 1970 1.78 4234 6.24 6814 4.21 5574 1.22 3039 1.74 114 0.00
44 2023-11-04 23657 4.07 1904 2.15 4506 6.88 6997 5.80 6544 1.79 3562 2.36 144 2.78
45 2023-11-11 24764 5.12 2058 2.77 4680 7.97 7241 7.62 7201 2.14 3459 3.58 125 6.40
46 2023-11-18 26517 5.85 2195 2.41 4910 10.14 7796 7.91 8237 2.87 3258 4.27 121 7.44
47 2023-11-25 27491 6.81 2363 4.70 4975 11.82 8068 8.66 8508 3.24 3445 5.28 132 11.36
48 2023-12-02 30258 6.99 2549 5.88 5533 11.46 8447 8.49 9797 3.57 3783 6.66 149 8.72
49 2023-12-09 31232 7.38 2665 7.69 5930 11.11 8465 7.40 10436 4.53 3475 9.35 261 6.90
50 2023-12-16 34607 7.26 3004 8.46 7537 9.73 9261 5.99 10173 5.17 4347 9.50 285 10.53
51 2023-12-23 35988 7.29 3258 9.45 8774 9.14 9244 4.64 9820 6.47 4615 9.36 277 6.14
52 2023-12-30 37639 7.41 3431 8.57 9849 7.53 9829 4.62 9130 8.48 5196 9.49 204 15.69
1 2024-01-06 37934 7.10 3630 9.12 9953 7.31 9871 4.03 8828 7.56 5404 9.88 248 13.71
2 2024-01-13 35286 6.26 3383 9.16 9029 6.14 9975 3.27 7930 7.65 4737 7.81 232 17.67
3 2024-01-20 30827 6.13 2936 9.91 7837 5.82 8808 2.99 6892 8.21 4214 6.76 140 20.00
4 2024-01-27 30616 5.85 3067 10.01 7786 5.48 8260 2.62 6810 6.83 4514 7.35 179 24.02
5 2024-02-03 30446 5.91 3235 9.52 7985 5.07 7736 2.12 6932 8.18 4426 7.32 132 24.24
6 2024-02-10 29075 5.21 2949 10.07 7832 4.60 7404 1.62 6794 6.74 3937 6.27 159 20.75
7 2024-02-17 29028 4.49 2610 8.12 7969 4.56 7689 1.16 6769 6.04 3846 4.91 145 27.59
8 2024-02-24 28917 4.78 2715 7.18 8169 4.55 7189 1.14 6600 6.83 4057 5.57 187 29.41
9 2024-03-02 28626 3.79 2712 6.42 8150 3.99 7134 1.23 6368 4.35 4096 4.32 166 26.51
10 2024-03-09 27634 3.64 2700 6.52 7381 4.09 6873 0.89 6407 3.59 4043 3.96 230 33.91
11 2024-03-16 26585 3.18 3019 5.13 6559 3.58 6948 0.88 5896 3.43 3935 3.66 228 21.05
12 2024-03-23 26748 2.49 2944 3.53 6480 3.33 6961 0.49 6396 2.94 3707 2.81 260 7.69
13 2024-03-30 26067 2.32 2642 3.14 6609 3.78 6384 0.58 6649 2.20 3555 1.83 228 10.96
14 2024-04-06 26397 2.08 2685 2.76 6714 3.07 6704 0.69 6709 2.04 3364 2.02 221 8.60
15 2024-04-13 25527 1.79 2716 2.06 6644 2.57 6232 0.64 6678 1.99 3023 1.26 234 7.69
16 2024-04-20 22540 1.65 2470 1.74 6112 2.42 5976 0.67 5553 1.58 2238 1.65 191 8.90

Positive human parainfluenza virus (HPIV) tests

Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Figure 6
Figure 6: Positive human parainfluenza virus (HPIV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HPIV% Atl Tests HPIV% QC Tests HPIV% ON Tests HPIV% Pr Tests HPIV% BC Tests HPIV%
35 2023-09-02 6234 1.99 362 1.38 847 3.90 3406 1.85 984 1.02 635 2.05
36 2023-09-09 6321 1.49 355 1.69 868 2.19 3420 1.43 1133 0.97 545 1.65
37 2023-09-16 7419 1.60 401 2.49 1053 2.18 3886 1.34 1326 1.06 753 2.66
38 2023-09-23 8139 1.77 430 2.79 1122 2.85 4366 1.74 1445 0.90 776 1.42
39 2023-09-30 8627 1.32 401 1.25 1117 1.88 4948 1.33 1415 1.06 746 0.94
40 2023-10-07 8791 1.34 467 3.43 1178 2.04 4850 1.20 1541 0.39 755 1.85
41 2023-10-14 8879 1.28 491 1.63 1094 1.37 4898 1.16 1638 1.04 758 2.24
42 2023-10-21 9281 1.59 498 2.21 1050 1.52 5293 1.51 1707 1.46 733 2.18
43 2023-10-28 9085 1.21 474 1.48 1063 1.98 5223 0.96 1656 0.85 669 2.69
44 2023-11-04 9496 1.44 492 2.24 1067 2.06 5215 1.00 1938 1.24 784 3.57
45 2023-11-11 9826 1.65 467 2.78 1257 1.83 5242 1.11 2076 1.35 784 5.10
46 2023-11-18 10441 1.39 500 2.20 1426 1.33 5505 1.24 2191 0.87 819 3.42
47 2023-11-25 10872 1.55 620 1.77 1442 1.04 5708 1.47 2195 1.18 907 3.53
48 2023-12-02 11676 1.51 676 2.37 1587 1.32 5967 1.39 2463 1.10 983 2.95
49 2023-12-09 11621 1.39 668 1.65 1630 1.10 6040 1.44 2537 1.14 746 2.14
50 2023-12-16 12631 1.46 730 1.92 1664 0.72 6696 1.36 2459 1.46 1082 2.96
51 2023-12-23 12648 1.35 768 1.56 1857 0.54 6421 1.46 2408 0.79 1194 3.02
52 2023-12-30 12871 1.35 709 1.55 2004 0.85 6809 1.29 2168 0.97 1181 3.13
1 2024-01-06 13434 1.48 812 1.72 2046 0.59 7059 1.60 2288 1.18 1229 2.69
2 2024-01-13 13182 1.17 924 1.73 1882 0.53 7137 1.16 2111 1.09 1128 1.95
3 2024-01-20 11423 1.08 704 1.28 1843 0.49 6099 1.18 1774 1.13 1003 1.30
4 2024-01-27 11007 1.16 834 0.72 1793 0.28 5677 1.41 1707 1.41 996 1.31
5 2024-02-03 11179 1.45 794 1.26 1833 0.55 5534 1.66 1933 1.86 1085 1.29
6 2024-02-10 10714 1.56 782 0.77 1832 0.49 5194 1.73 1937 1.55 969 3.30
7 2024-02-17 10731 1.54 619 1.29 1863 0.54 5369 1.42 1898 2.32 982 2.75
8 2024-02-24 10455 1.84 632 0.47 1825 1.59 5114 1.82 1905 2.20 979 2.55
9 2024-03-02 10419 2.40 587 1.02 1800 1.11 5157 2.83 1793 2.90 1082 2.40
10 2024-03-09 9897 2.74 483 2.69 1681 1.84 4982 2.65 1749 3.66 1002 3.09
11 2024-03-16 9750 3.43 626 1.92 1433 1.88 5071 3.45 1624 4.99 996 3.92
12 2024-03-23 9990 4.10 592 3.21 1588 2.33 5076 4.10 1810 4.92 924 6.17
13 2024-03-30 9394 4.52 581 3.96 1540 3.70 4578 4.59 1768 4.69 927 5.61
14 2024-04-06 9666 4.52 597 4.69 1640 3.48 4695 4.35 1854 5.50 880 5.23
15 2024-04-13 9503 5.96 626 7.35 1624 4.31 4485 5.11 1925 8.47 843 6.88
16 2024-04-20 8697 5.50 568 7.75 1600 3.19 4269 5.67 1484 5.66 776 7.35

Positive adenovirus (ADV) tests

Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Figure 7
Figure 7: Positive adenovirus (ADV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests ADV% Atl Tests ADV% QC Tests ADV% ON Tests ADV% Pr Tests ADV% BC Tests ADV%
35 2023-09-02 6238 1.62 362 1.93 851 2.70 3406 0.91 984 2.44 635 2.52
36 2023-09-09 6332 1.52 355 1.97 879 2.28 3420 0.82 1133 2.03 545 3.30
37 2023-09-16 7438 1.47 401 2.00 1071 2.43 3887 0.90 1326 1.96 753 1.86
38 2023-09-23 8149 0.93 429 1.17 1134 1.06 4365 0.62 1445 1.59 776 1.16
39 2023-09-30 8614 1.15 401 1.00 1129 2.04 4923 0.69 1415 1.63 746 2.01
40 2023-10-07 8809 1.41 467 2.36 1195 2.85 4851 0.66 1541 1.69 755 2.78
41 2023-10-14 8913 1.38 491 1.63 1111 3.42 4915 0.75 1638 1.47 758 2.11
42 2023-10-21 9286 1.43 498 1.20 1058 3.59 5292 0.76 1705 1.47 733 3.27
43 2023-10-28 9099 1.48 474 2.74 1077 3.62 5223 0.69 1656 1.63 669 2.99
44 2023-11-04 9514 1.76 492 2.03 1085 3.87 5215 1.04 1938 2.12 784 2.55
45 2023-11-11 9843 1.45 467 2.57 1274 2.98 5242 0.92 2076 1.64 784 1.40
46 2023-11-18 10452 2.03 500 4.60 1437 4.31 5505 0.94 2191 1.92 819 4.03
47 2023-11-25 10920 1.90 620 2.74 1461 3.97 5712 1.07 2194 1.50 911 3.84
48 2023-12-02 11737 2.15 676 3.25 1613 3.84 5967 1.36 2462 2.03 983 3.05
49 2023-12-09 11699 1.83 668 2.84 1652 3.75 6041 1.18 2537 1.26 746 3.62
50 2023-12-16 12719 2.00 730 2.19 1681 3.09 6696 1.78 2459 1.67 1082 2.40
51 2023-12-23 12035 1.55 768 1.82 1875 2.61 5726 0.89 2408 1.45 1194 3.02
52 2023-12-30 10983 1.76 709 2.12 2010 2.49 4852 0.80 2167 1.43 1181 4.74
1 2024-01-06 11675 1.48 812 1.11 2050 2.20 5219 0.75 2288 1.14 1229 4.15
2 2024-01-13 12078 1.25 924 1.52 1901 2.31 5943 0.59 2111 1.33 1126 2.49
3 2024-01-20 11461 1.11 704 1.56 1851 1.19 6091 0.64 1774 1.35 1003 2.89
4 2024-01-27 11062 1.56 834 2.88 1807 2.32 5675 0.78 1706 1.64 996 3.41
5 2024-02-03 11223 1.62 794 2.90 1841 2.55 5534 0.74 1933 1.55 1085 3.59
6 2024-02-10 10761 1.84 782 3.45 1852 2.59 5192 0.67 1935 1.45 969 5.88
7 2024-02-17 10779 1.22 619 1.29 1875 1.97 5369 0.60 1898 1.16 982 2.95
8 2024-02-24 10525 1.30 632 2.06 1837 2.01 5114 0.80 1905 0.89 979 2.96
9 2024-03-02 10484 1.65 587 4.26 1822 2.25 5157 1.01 1793 1.06 1082 2.87
10 2024-03-09 9989 1.31 483 1.86 1708 1.70 4982 0.78 1748 1.54 1002 2.30
11 2024-03-16 9808 1.29 626 1.44 1458 1.99 5072 0.79 1623 1.48 996 2.41
12 2024-03-23 10056 1.42 592 1.35 1614 1.49 5076 1.18 1809 1.00 924 3.46
13 2024-03-30 9442 1.63 581 2.07 1565 3.07 4578 0.87 1768 0.96 927 3.99
14 2024-04-06 9717 1.58 597 2.01 1657 3.02 4695 0.75 1853 1.03 880 4.20
15 2024-04-13 9548 1.39 626 2.08 1640 2.13 4485 1.11 1925 0.68 843 2.61
16 2024-04-20 8737 1.53 568 2.46 1617 2.23 4269 0.98 1484 1.15 771 3.11

Positive human metapneumovirus (HMPV) tests

Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Figure 8
Figure 8: Positive human metapneumovirus (HMPV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HMPV% Atl Tests HMPV% QC Tests HMPV% ON Tests HMPV% Pr Tests HMPV% BC Tests HMPV%
35 2023-09-02 6260 0.34 362 0.00 848 1.42 3407 0.21 1008 0.10 635 0.16
36 2023-09-09 6354 0.39 355 0.28 867 1.38 3423 0.20 1164 0.26 545 0.37
37 2023-09-16 7455 0.39 401 0.50 1053 0.76 3886 0.36 1362 0.07 753 0.53
38 2023-09-23 8194 0.38 429 0.00 1124 1.07 4365 0.14 1500 0.13 776 1.42
39 2023-09-30 8680 0.51 401 0.25 1118 0.89 4948 0.36 1467 0.34 746 1.34
40 2023-10-07 8828 0.32 457 0.44 1180 0.76 4853 0.14 1583 0.32 755 0.66
41 2023-10-14 8911 0.37 484 0.00 1096 1.00 4915 0.20 1658 0.12 758 1.32
42 2023-10-21 9321 0.46 498 0.20 1050 1.33 5298 0.32 1742 0.17 733 1.09
43 2023-10-28 9083 0.46 474 0.63 1066 1.41 5200 0.31 1674 0.18 669 0.75
44 2023-11-04 9519 0.55 492 0.20 1070 1.96 5218 0.17 1955 0.61 784 1.15
45 2023-11-11 9825 0.60 467 0.21 1256 2.15 5244 0.21 2074 0.63 784 0.89
46 2023-11-18 10315 0.79 500 0.40 1426 2.38 5505 0.36 2180 0.37 704 2.56
47 2023-11-25 10920 1.00 620 0.97 1442 2.57 5715 0.44 2210 0.59 911 2.96
48 2023-12-02 11703 0.91 676 0.89 1585 2.33 5965 0.47 2458 0.49 983 2.34
49 2023-12-09 11654 1.20 668 1.20 1635 2.39 6037 0.61 2513 1.95 746 0.94
50 2023-12-16 12683 1.31 730 1.78 1669 2.52 6707 0.63 2424 1.61 1082 2.77
51 2023-12-23 12659 1.59 768 1.56 1857 2.48 6415 0.78 2361 2.50 1194 2.85
52 2023-12-30 12881 1.76 709 2.26 2006 2.14 6809 0.98 2112 2.27 1181 4.49
1 2024-01-06 13431 2.20 812 1.85 2048 2.15 7012 1.07 2253 3.99 1229 5.78
2 2024-01-13 13207 1.64 924 1.41 1887 1.59 7144 0.62 2053 3.85 1126 4.26
3 2024-01-20 11426 2.20 704 1.56 1837 2.34 6103 1.23 1741 4.19 1003 4.79
4 2024-01-27 11026 2.11 834 1.92 1793 1.78 5678 1.13 1681 4.34 996 4.82
5 2024-02-03 11160 2.27 794 2.39 1831 2.46 5534 1.36 1880 2.87 1085 5.44
6 2024-02-10 10709 2.54 782 2.94 1828 2.63 5191 1.58 1908 2.62 969 7.12
7 2024-02-17 10757 2.82 619 2.91 1864 3.70 5376 2.14 1880 1.91 982 6.62
8 2024-02-24 10425 3.15 632 3.96 1825 2.79 5113 2.62 1818 2.31 979 7.76
9 2024-03-02 10398 3.92 587 3.75 1802 4.99 5157 3.37 1727 2.49 1082 7.30
10 2024-03-09 9915 4.57 483 5.38 1677 5.66 4991 4.49 1696 1.83 1002 7.58
11 2024-03-16 9742 4.88 626 7.67 1433 5.65 5084 4.76 1570 2.04 996 7.13
12 2024-03-23 9948 4.63 592 5.57 1589 5.48 5085 4.90 1717 1.75 924 6.71
13 2024-03-30 9329 5.02 581 7.40 1536 6.90 4589 4.73 1673 1.61 927 8.09
14 2024-04-06 9626 5.14 597 7.54 1639 7.02 4699 5.60 1776 1.35 880 5.34
15 2024-04-13 9418 4.63 626 5.43 1618 5.69 4489 5.57 1813 0.94 843 5.10
16 2024-04-20 8641 5.30 568 6.16 1600 7.50 4271 5.85 1403 1.28 771 4.54

Positive enterovirus/rhinovirus (EV/RV) tests

Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Figure 9
Figure 9: Positive enterovirus/rhinovirus (EV/RV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests EV/RV% Atl Tests EV/RV% QC Tests EV/RV% ON Tests EV/RV% Pr Tests EV/RV% BC Tests EV/RV%
35 2023-09-02 5345 12.50 362 20.72 - - 3409 10.44 966 14.60 608 15.79
36 2023-09-09 5414 14.85 355 25.35 - - 3423 12.80 1119 16.80 516 17.05
37 2023-09-16 6331 18.29 401 23.69 - - 3887 16.08 1314 22.37 722 19.81
38 2023-09-23 6991 20.25 429 27.51 - - 4365 17.11 1428 25.14 747 24.63
39 2023-09-30 7479 18.52 401 26.43 - - 4948 15.74 1398 22.17 715 25.31
40 2023-10-07 7559 17.45 467 23.55 - - 4853 14.77 1515 20.99 706 23.80
41 2023-10-14 7762 15.74 491 23.01 - - 4915 13.77 1612 16.00 717 23.15
42 2023-10-21 8204 13.12 498 22.09 - - 5298 10.82 1681 13.50 695 22.16
43 2023-10-28 7977 12.52 474 16.03 - - 5227 9.95 1624 15.58 637 23.23
44 2023-11-04 8385 10.83 492 17.07 - - 5218 8.39 1916 12.21 736 20.52
45 2023-11-11 8530 10.70 467 16.70 - - 5244 8.68 2051 10.48 743 21.53
46 2023-11-18 8958 8.64 500 14.20 - - 5506 6.79 2161 8.42 779 18.87
47 2023-11-25 9427 7.62 620 11.94 - - 5716 5.86 2186 7.55 883 15.63
48 2023-12-02 10068 6.79 676 9.76 - - 5970 5.19 2427 6.47 959 15.43
49 2023-12-09 9980 6.00 668 6.74 - - 6046 4.50 2516 6.20 695 17.70
50 2023-12-16 11005 5.90 730 7.81 - - 6708 4.62 2437 4.97 1059 14.45
51 2023-12-23 10800 5.56 768 6.51 - - 6434 3.73 2380 5.88 1154 14.47
52 2023-12-30 10881 4.71 709 5.50 - - 6808 3.30 2155 4.83 1145 12.31
1 2024-01-06 11366 4.80 812 4.43 - - 7012 3.76 2268 5.51 1197 9.69
2 2024-01-13 11322 4.43 924 4.22 - - 7146 3.20 2090 5.07 1089 11.48
3 2024-01-20 9564 4.59 704 4.26 - - 6103 3.16 1751 6.40 968 10.02
4 2024-01-27 9212 4.37 834 4.68 - - 5678 3.12 1695 6.02 961 8.43
5 2024-02-03 9317 5.02 794 5.54 - - 5534 3.27 1918 7.66 1035 9.08
6 2024-02-10 8831 6.26 782 8.82 - - 5191 4.26 1909 7.54 918 12.42
7 2024-02-17 8854 6.18 619 6.30 - - 5376 4.35 1882 8.29 941 12.01
8 2024-02-24 8644 6.21 632 5.85 - - 5113 4.99 1896 7.23 945 10.69
9 2024-03-02 8601 6.48 587 6.30 - - 5157 4.65 1773 7.61 1041 13.74
10 2024-03-09 8230 6.52 483 9.11 - - 4991 4.81 1734 7.55 956 12.45
11 2024-03-16 8300 6.67 626 6.55 - - 5084 5.39 1593 7.34 964 12.03
12 2024-03-23 8413 6.63 592 7.26 - - 5085 5.45 1795 7.30 900 11.56
13 2024-03-30 7851 7.36 581 8.61 - - 4589 5.14 1747 9.90 911 12.84
14 2024-04-06 8012 7.54 598 10.54 - - 4699 6.11 1828 8.97 852 9.98
15 2024-04-13 7828 8.51 626 11.98 - - 4462 6.99 1902 9.94 809 10.63
16 2024-04-20 7087 9.44 568 11.62 - - 4271 7.82 1465 9.42 755 16.56

Positive human coronavirus (HCoV) tests

Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Figure 10
Figure 10: Positive human coronavirus (HCoV) tests (%) in Canada by region by surveillance week
Week Week End Can Tests HCoV% Atl Tests HCoV% QC Tests HCoV% ON Tests HCoV% Pr Tests HCoV% BC Tests HCoV%
35 2023-09-02 5054 0.28 362 0.00 847 0.47 2230 0.13 1007 0.60 608 0.16
36 2023-09-09 5195 0.42 355 0.56 868 0.81 2285 0.09 1171 0.77 516 0.39
37 2023-09-16 6174 0.23 401 0.50 1053 0.47 2636 0.23 1362 0.00 722 0.14
38 2023-09-23 6796 0.46 429 0.00 1122 0.80 2995 0.40 1503 0.40 747 0.54
39 2023-09-30 7026 0.28 401 0.00 1117 0.45 3325 0.21 1468 0.48 715 0.14
40 2023-10-07 7305 0.26 467 0.21 1178 0.08 3390 0.18 1587 0.25 683 1.02
41 2023-10-14 7435 0.32 491 0.20 1094 0.73 3461 0.12 1672 0.60 717 0.14
42 2023-10-21 7697 0.17 498 0.20 1050 0.48 3707 0.05 1747 0.23 695 0.14
43 2023-10-28 7576 0.38 473 0.42 1065 0.38 3707 0.30 1694 0.53 637 0.47
44 2023-11-04 7754 0.37 476 0.21 1067 0.28 3508 0.43 1967 0.20 736 0.82
45 2023-11-11 8119 0.42 467 0.86 1187 0.51 3607 0.28 2115 0.38 743 0.81
46 2023-11-18 8674 0.65 500 0.20 1324 0.98 3838 0.42 2233 0.99 779 0.51
47 2023-11-25 9069 0.65 620 0.65 1357 0.96 3977 0.55 2232 0.54 883 0.91
48 2023-12-02 9880 0.76 676 0.74 1518 1.05 4241 0.42 2486 0.72 959 1.88
49 2023-12-09 9440 1.12 668 1.20 1523 1.64 4007 0.57 2547 1.33 695 2.30
50 2023-12-16 10458 1.47 730 0.41 1583 1.58 4616 1.47 2470 1.58 1059 1.79
51 2023-12-23 10483 1.77 768 1.30 1765 2.10 4389 1.66 2407 1.58 1154 2.43
52 2023-12-30 10328 2.48 709 1.55 1885 2.97 4422 2.49 2167 2.08 1145 2.97
1 2024-01-06 10903 3.06 812 2.96 1861 2.10 4722 3.37 2311 2.81 1197 3.93
2 2024-01-13 10891 3.19 924 3.03 1719 2.50 5030 3.14 2129 3.85 1089 3.31
3 2024-01-20 9527 3.89 704 5.11 1698 4.18 4360 3.78 1797 3.78 968 3.20
4 2024-01-27 9111 5.19 834 5.28 1640 5.49 3941 5.76 1735 4.27 961 3.95
5 2024-02-03 9137 5.10 794 4.79 1647 5.10 3717 6.27 1944 3.34 1035 4.44
6 2024-02-10 8766 6.80 782 5.37 1653 9.50 3456 7.00 1957 5.01 918 6.21
7 2024-02-17 8846 7.73 619 6.30 1700 8.12 3661 8.96 1925 6.39 941 5.95
8 2024-02-24 8546 8.28 632 7.28 1644 10.28 3416 8.17 1909 7.02 945 8.47
9 2024-03-02 8590 7.09 587 6.47 1643 7.49 3511 8.32 1808 5.53 1041 5.38
10 2024-03-09 8072 6.84 483 4.97 1522 6.96 3342 8.02 1769 5.48 956 5.96
11 2024-03-16 8007 7.18 626 4.95 1287 7.30 3476 8.20 1654 6.83 964 5.39
12 2024-03-23 8202 6.79 592 6.08 1455 6.19 3452 7.42 1803 6.60 900 6.22
13 2024-03-30 7797 6.02 581 6.54 1418 5.92 3111 6.49 1776 5.01 911 6.15
14 2024-04-06 7932 6.77 598 7.19 1495 6.29 3134 6.83 1853 7.12 852 6.34
15 2024-04-13 7842 5.46 626 4.31 1509 5.57 2974 6.22 1924 4.68 809 5.19
16 2024-04-20 7058 5.03 568 6.34 1443 4.37 2807 5.20 1485 5.45 755 3.84

Page details

Date modified: